CHIPS Act Funding for Quantum Tech Spurs Legal Debate in Congress
Congress is questioning whether the $2.013B CHIPS Act investment in quantum tech exceeds legal authority.
Why it matters: Legal leaders advising on tech investment or contracts need clarity on CHIPS Act limits. Congressional challenge signals potential for audits, compliance reviews, or changes to future quantum R&D funding.
- The US Commerce Department will invest $2.013B in nine quantum tech companies through the CHIPS Act.
- IBM receives $1B for a quantum chip foundry, plus $1B matched from its own funds.
- Deals involve non-controlling government equity—designed to share upside, not manage firms.
- Rep. Zoe Lofgren says funding quantum projects may not be authorized under current CHIPS Act law.
The US Department of Commerce announced $2.013 billion in planned investments on May 21, 2026, targeting nine American quantum computing and tech companies. Quantum support comes via the CHIPS and Science Act, originally passed to bolster US semiconductor and microelectronics supply chains.
- IBM will get $1 billion for a new quantum chip factory, also investing $1 billion of its own.
- GlobalFoundries is set for $375 million for quantum device security manufacturing, with further awards of $38–100M to seven other firms, including D-Wave, Rigetti, and Infleqtion.
Each deal includes a small government equity interest — less than 50% — meaning Washington would not control management decisions but could share in company gains. This is similar to prior CHIPS Act semiconductor awards. Here, 'non-controlling equity' means the government simply holds shares but cannot direct company policies.
However, the legal basis for this funding is disputed. Rep. Zoe Lofgren (D-CA) contends the CHIPS Act is "explicitly limited" to microelectronics: "Using these funds for quantum is illegal and troubling." She has called for an Inspector General review.
An independent law professor told LegalTech Digest that while the statute's focus is on semiconductors, its broader R&D section could be interpreted to allow quantum awards, though only if Congress intended the law to stretch that far. Legal and compliance teams must monitor for clarifications or legal challenges, as expanded statutory authority may be tested in court or oversight agencies.
Commerce emphasizes these investments as crucial for America’s technology leadership. But with the challenge in Congress, contract counsel should review quantum funding terms and be alert to legal risks tied to eligibility and oversight requirements.
By the numbers:
- $2.013B — Total federal investment in nine US quantum tech firms
- $1B — Largest single award, to IBM for building a quantum chip facility
- <50% — Size of government equity stakes, ensuring no controlling interest
Yes, but: A legal challenge or inspector general review could delay or rescind some awards if found noncompliant with the CHIPS Act.
What's next: Congress may hold hearings on the legality of these quantum tech funds; a potential Inspector General review is pending.